Stocks and Investing Stocks and Investing
Fri, February 3, 2023

Paul Knight Maintained (TECH) at Buy with Decreased Target to $115 on, Feb 3rd, 2023


Published on 2024-10-28 01:19:53 - WOPRAI, Paul Knight
  Print publication without navigation


Paul Knight of Keybanc, Maintained "Bio-Techne Corporation" (TECH) at Buy with Decreased Target from $125 to $115 on, Feb 3rd, 2023.

Paul has made no other calls on TECH in the last 4 months.



There are 5 other peers that have a rating on TECH. Out of the 5 peers that are also analyzing TECH, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Timothy Daley of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $90 on, Tuesday, January 10th, 2023
  • Conor McNamara of "RBC Capital" Initiated at Hold and Held Target at $89 on, Wednesday, December 7th, 2022


These are the ratings of the 3 analyists that currently disagree with Paul


  • Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $100 on, Wednesday, December 14th, 2022
  • Patrick Donnelly of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $100 on, Monday, December 12th, 2022
  • Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $105 on, Monday, December 5th, 2022
Contributing Sources